2010
DOI: 10.1016/j.healun.2009.11.209
|View full text |Cite
|
Sign up to set email alerts
|

199: Use of Induction Agents and Incidence of Infection and Malignancy Following Pediatric Heart Transplantation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2010
2010
2010
2010

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 1 publication
0
1
0
Order By: Relevance
“…They also likely play a role in facilitating complete steroid avoidance regimens [10•]. & A recent analysis of more than 2,300 heart recipients within the Pediatric Heart Transplant Study showed no evidence of increased infection or malignancy with induction therapy [16]. & There is no consensus that induction therapy prevents chronic rejection or improves graft or patient survival.…”
Section: Treatment Induction Therapymentioning
confidence: 99%
“…They also likely play a role in facilitating complete steroid avoidance regimens [10•]. & A recent analysis of more than 2,300 heart recipients within the Pediatric Heart Transplant Study showed no evidence of increased infection or malignancy with induction therapy [16]. & There is no consensus that induction therapy prevents chronic rejection or improves graft or patient survival.…”
Section: Treatment Induction Therapymentioning
confidence: 99%